370 related articles for article (PubMed ID: 34200095)
21. The gut microbiota heterogeneity and assembly changes associated with the IBD.
Sun Y; Li L; Xia Y; Li W; Wang K; Wang L; Miao Y; Ma S
Sci Rep; 2019 Jan; 9(1):440. PubMed ID: 30679676
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
Shamoon M; Martin NM; O'Brien CL
Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
25. Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases.
Thomann AK; Mak JWY; Zhang JW; Wuestenberg T; Ebert MP; Sung JJY; Bernstein ÇN; Reindl W; Ng SC
Aliment Pharmacol Ther; 2020 Jul; 52(2):247-266. PubMed ID: 32525605
[TBL] [Abstract][Full Text] [Related]
26. [The role of gut microbiota dysbiosis in the occurrence and development of inflammatory bowel disease and its prevention and control strategies].
Yang ZY; Li M
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1175-1181. PubMed ID: 36207877
[TBL] [Abstract][Full Text] [Related]
27. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
[TBL] [Abstract][Full Text] [Related]
29. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
30. Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
Healey GR; Celiberto LS; Lee SM; Jacobson K
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092150
[TBL] [Abstract][Full Text] [Related]
31. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
Gonçalves P; Araújo JR; Di Santo JP
Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
[TBL] [Abstract][Full Text] [Related]
32. Digestive Inflammation: Role of Proteolytic Dysregulation.
Mariaule V; Kriaa A; Soussou S; Rhimi S; Boudaya H; Hernandez J; Maguin E; Lesner A; Rhimi M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802197
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
34. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
35. Nutrition, IBD and Gut Microbiota: A Review.
Mentella MC; Scaldaferri F; Pizzoferrato M; Gasbarrini A; Miggiano GAD
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235316
[TBL] [Abstract][Full Text] [Related]
36. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
Weingarden AR; Vaughn BP
Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
[TBL] [Abstract][Full Text] [Related]
37. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases.
Li H; Christman LM; Li R; Gu L
Food Funct; 2020 Jun; 11(6):4878-4891. PubMed ID: 32490857
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota in chronic inflammatory disorders: A focus on pediatric inflammatory bowel diseases and juvenile idiopathic arthritis.
Ricciuto A; Sherman PM; Laxer RM
Clin Immunol; 2020 Jun; 215():108415. PubMed ID: 32278875
[TBL] [Abstract][Full Text] [Related]
39. Determinants of IBD Heritability: Genes, Bugs, and More.
Turpin W; Goethel A; Bedrani L; Croitoru Mdcm K
Inflamm Bowel Dis; 2018 May; 24(6):1133-1148. PubMed ID: 29701818
[TBL] [Abstract][Full Text] [Related]
40. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.
Lamas B; Martins Breyner N; Houdeau E
Part Fibre Toxicol; 2020 Jun; 17(1):19. PubMed ID: 32487227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
